|
Lee Tien-Li
|
Chief Executive Officer |
Aardvark Therapeutics, Inc. (AARD)
|
2025-12-11 |
$14.48 |
0.0% |
7,000
|
$101,395 |
|
Sun Nelson
|
Chief Financial Officer |
Aardvark Therapeutics, Inc. (AARD)
|
2025-12-11 |
$14.40 |
0.0% |
3,000
|
$43,200 |
|
Lee Tien-Li
|
Chief Executive Officer |
Aardvark Therapeutics, Inc. (AARD)
|
2025-09-15 |
$9.66 |
0.0% |
10,000
|
$96,624 |
|
Lee Tien-Li
|
Chief Executive Officer |
Aardvark Therapeutics, Inc. (AARD)
|
2025-09-12 |
$8.03 |
0.0% |
20,000
|
$160,654 |
|
Sun Nelson
|
Chief Financial Officer |
Aardvark Therapeutics, Inc. (AARD)
|
2025-09-09 |
$8.07 |
0.0% |
6,000
|
$48,440 |
|
Sun Nelson
|
Chief Financial Officer |
Aardvark Therapeutics, Inc. (AARD)
|
2025-02-14 |
$16.00 |
0.0% |
10,000
|
$160,000 |
|
Lee Tien-Li
|
Chief Executive Officer |
Aardvark Therapeutics, Inc. (AARD)
|
2025-02-14 |
$16.00 |
0.0% |
16,542
|
$264,672 |
|
Decheng Capital Global Life Sciences Fund Iv, L.P.
|
Non-Executive |
Aardvark Therapeutics, Inc. (AARD)
|
2025-02-14 |
$16.00 |
0.0% |
1,250,000
|
$20,000,000 |